Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.

Saved in:
Bibliographic Details
Title: Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
Authors: Parsons DW; Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX., Janeway KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Patton DR; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD., Winter CL; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD., Coffey B; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD., Roy-Chowdhuri S; University of Texas MD Anderson Cancer Center, Houston, TX., Tsongalis GJ; Geisel School of Medicine at Dartmouth, Hanover, NH.; Dartmouth Hitchcock Medical Center, Lebanon, NH., Routbort M; University of Texas MD Anderson Cancer Center, Houston, TX., Ramirez NC; Biopathology Center, Research Institute at Nationwide Children's Hospital, Columbus, OH., Saguilig L; Children's Oncology Group Statistical Center, Monrovia, CA., Piao J; Keck School of Medicine, University of Southern California, Los Angeles, CA., Alonzo TA; Keck School of Medicine, University of Southern California, Los Angeles, CA., Berg SL; Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX., Fox E; St Jude Children's Research Hospital, Memphis, TN., Hawkins DS; Seattle Children's Hospital and University of Washington, Seattle, WA., Abrams JS; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD., Mooney M; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD., Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD., Seibel NL; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.
Corporate Authors: NCI-COG Pediatric MATCH Team
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Jul 10; Vol. 40 (20), pp. 2224-2234. Date of Electronic Publication: 2022 Mar 30.
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-7755
DOI:10.1200/JCO.21.02838